Original Publication Date: 1 February, 2016
Publication / Source: Breast Cancer Management
Authors: Abiola Ibraheem, Trista J Stankowski-Drengler, Olumide B Gbolahan, Jessica M Engel & Adedayo A Onitilo
Chemotherapy-induced cardiotoxicity (CIC) is a well-documented side effect of breast cancer treatment. Nearly all chemotherapeutic agents can cause CIC with the highest occurrence found in anthracycline and trastuzumab use. Treatment- and patient-related risk factors contribute to the development of CIC making risk modification an important consideration during breast cancer treatment.